NEW YORK, Sept. 3, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, admits filing of a class action lawsuit on behalf of purchasers of Abbott Laboratories (NYSE: ABT) securities between February 19, 2021 and 8 “school hours”). If you want to appear as lead plaintiff, you must call the court not later than October 312022.

SO WHAT: If you purchased Abbott securities during the Class Period, you may be entitled to compensation without payment of expenses or costs through a contingency fee arrangement.

WHAT TO DO NEXTT: To join the Abbott Class Action, go to https://rosenlegal.com/submit-form/?case_id=8453 or call Phillip Kim, Esq. toll free at 866-767-3653 or by email [email protected] or [email protected] for information about the Class Action. A class action lawsuit has already been filed. If you want to appear as lead plaintiff, you must call the court not later than October 312022. A lead plaintiff is a representative party acting on behalf of other group members in conducting the litigation.

WHY ROSES LAW: We encourage investors to select qualified advisors with a track record in leadership positions. Frequently, companies that issue notices do not have comparable experience, resources, or meaningful recognition from peers. Be wise in choosing a lawyer. The Rosen Law Firm represents investors worldwide and focuses its practice on securities class actions and shareholder derivatives litigation. Rosen Law Firm has achieved the largest-ever settlement of a securities class action lawsuit against a Chinese company. Rosen Law Firm was ranked #1 in 2017 by ISS Securities Class Action Services for the number of securities class action settlements. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company secured over $438 million for investors. In 2020, founding partner Laurence Rosen…